Table: Stemcell Institute -2022/23 parent results
May 11 (Reuters)-
Stemcell Institute
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 2.09 1.78 2.51
(+17.4 pct) (+26.4 pct) (+20.0 pct)
Operating 297 mln 226 mln 451 mln
(+31.1 pct) (+161.2 pct) (+51.8 pct)
Recurring 300 mln 212 mln 451 mln
(+41.3 pct) (+130.0 pct) (+50.4 pct)
Net 198 mln 133 mln 300 mln
(+48.1 pct) (+114.4 pct) (+51.5 pct)
EPS 19.33 yen 13.20 yen 29.28 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Stemcell Institute.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7096.T